Tag Archives: 1st pitch

1st Pitch Life Sciences Meeting – April 14

Posted on by
Reply

Eavesdropping on Investors’ Closed Door Discussions”

1st Pitch Life Sciences Meeting

Tuesday, April 14, 2015

5:30pm – 8:30pm

Hear what happens after a start-up company presents to an investor group. Usually after the company representatives leave the room the investors have a private discussion to decide whether the opportunity merits further investigation and possible investment. 1st Pitch Life Science offers presenters and audience members the chance to hear what happens in those closed-door discussion, and to learn what really matters to investors.

1st Pitch Life Science is organized by MABA (Mid Atlantic Bio Angels www.bioangels.net), a life science investor group, to encourage and educate aspiring life science entrepreneurs who know they may be too early or not fully prepared to seek investment but want the opportunity to practice their pitch and to receive constructive criticism from experienced and knowledgeable professionals.

To Register: https://1stpitchapril2015.eventbrite.com

When: Tuesday, April 14th, 2015

5:30pm : Registration & Networking

6:00 – 8:00pm : Program

8:00 – 8:30pm : Networking

Where:** Please note new location**

New York Genome Center

101 Avenue of the Americas

New York, NY 10013

 

Symbiotic Health Wins Best in Show at 1st Pitch Competition

Posted on by
Reply

Symbiotic Health, Inc, a New York City based company and Center for Biotechnology client, was named “Best in Show” at the first of MABA’s 1st Pitch Life Science events in 2015, Symbiotic Health has developed a capsule to help kill Clostridium difficile (Cdiff) infection which causes severe, debilitating diarrhea, is the most frequent hospital-acquired infection in the US and an immediate public health threat that requires urgent and immediate action (CDC). The company’s pipeline includes a capsule microbiome therapeutic designed to cure Cdiff by restoring a community of protective bacteria.

Dr. Gerard Honig, CEO of Symbiotic Health, presented on behalf of the company. Stephen M. Goodman, Co-founder of Mid Atlantic Bio Angels and a partner at Pryor Cashman LLP in New York City, also a panelist at the event said Dr. Honig’s pitch and responses to questions demonstrated both mastery of the competitive space and a willingness to address challenges to his analysis calmly and directly. His style, as well as his substance, exemplified the maxim that it’s not just the business plan but the management that ultimately brings a company success. Read more about the company and the competition here.